EUVIMEDEUVIMED entdecken
Crossref

Anticholinergic and central nervous system‐active drug burdens and their associations with adverse in‐hospital outcomes among older inpatients

Kittipak Jenghua iD, Jariya Ratcharoen iD, Thidapon Wannathong iD, Awitra Phumsod iD, Chantra Khumsorn iD, Noppaket Singkham iD, Duangkamon Poolpun iD

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Kittipak Jenghua und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Care, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand. Hauptthemen laut MEDLINE: Cholinergic Antagonists, Hospitalization, Central Nervous System Agents. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Thailand Science Research and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Anticholinergic (ACh) and central nervous system (CNS)‐active drug burdens may be associated with adverse outcomes in older adults. This study assessed these burdens and examined their associations with adverse in‐hospital outcomes.

Methods

A retrospective cross‐sectional analysis was conducted among 13 607 hospitalizations in patients aged ≥60 years in 2024. ACh burden was assessed using the 2022 CRIDECO Anticholinergic Load Scale, and the 2023 Beers Criteria were used to assess CNS‐active burden. For each exposure, hospitalizations were classified as having no, low, or high burden. The primary outcome was a composite of delirium, cognitive impairment, falls or fractures. Secondary outcomes included length of stay, in‐hospital mortality and hospitalization costs. Separate multivariable regression models were used to estimate associations with ACh and CNS‐active burdens.

Results

Low and high ACh burdens were identified in 30.24% and 63.65% of hospitalizations, respectively; the corresponding proportions for CNS‐active burden were 49.17% and 21.99%. Compared with no ACh burden, high ACh burden was associated with the primary outcome (adjusted odds ratio [aOR] 8.40; 95% confidence interval [CI] 3.46–20.38), whereas low ACh burden was not. Compared with no CNS‐active burden, both low (aOR 4.67; 95% CI 2.67–8.18) and high (aOR 32.64; 95% CI 19.06–55.89) CNS‐active burdens were also associated with this outcome. High burden in either group was associated with longer hospital stay, higher mortality and greater costs.

Conclusions

ACh and CNS‐active burdens were associated with adverse in‐hospital outcomes, supporting consideration of routine inpatient medication reviews to identify potentially harmful cumulative drug burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinergic AntagonistsHospitalizationCentral Nervous System AgentsHumansFemaleRetrospective StudiesCross-Sectional StudiesAgedMaleLength of StayAged, 80 and overHospital MortalityInpatientsMiddle AgedHospital Costs

Stichwörter der Autor:innen

anticholinergic drugscentral nervous system‐active drugsdrug burdenin‐hospital outcomesolder patients

Substanzen

Cholinergic AntagonistsCentral Nervous System Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Care, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand.
  • Pharmacoepidemiology, Social and Administrative Pharmacy (PSAP) Research Unit, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand.
  • Research on Drug Utilization in Special Populations (RDU-SPEC) Research Unit, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand.
  • Department of Pharmacy, Buddhachinaraj Hospital, Phitsanulok Province, Thailand.

ORCID-Profile: Kittipak Jenghua, Jariya Ratcharoen, Thidapon Wannathong, Awitra Phumsod, Chantra Khumsorn, Noppaket Singkham, Duangkamon Poolpun

Förderung

  • Thailand Science Research and Innovation

Zitieren

APA

Jenghua, K., Ratcharoen, J., Wannathong, T., Phumsod, A., Khumsorn, C., Singkham, N., & Poolpun, D. (2026). Anticholinergic and central nervous system‐active drug burdens and their associations with adverse in‐hospital outcomes among older inpatients. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70682

Vancouver

Jenghua K, Ratcharoen J, Wannathong T, Phumsod A, Khumsorn C, Singkham N, et al. Anticholinergic and central nervous system‐active drug burdens and their associations with adverse in‐hospital outcomes among older inpatients. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70682

BibTeX
@article{Jenghua2026,
  author = {Jenghua, Kittipak and Ratcharoen, Jariya and Wannathong, Thidapon and Phumsod, Awitra and Khumsorn, Chantra and Singkham, Noppaket and Poolpun, Duangkamon},
  title = {Anticholinergic and central nervous system‐active drug burdens and their associations with adverse in‐hospital outcomes among older inpatients},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70682}
}
Kostenlos starten →